Type a ticker — we pressure-test it against live facts, filings, and sentiment.
Moderna, Inc. — Healthcare · Biotechnology carries a Plainview business-quality score of 5.9/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.
On the fundamentals, Moderna, Inc. shows trailing revenue of $2.22B, a 17.2% gross margin, net cash of $6.87B, a loss per share of -8.45, valued at about 9.7x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.
Compare: MRNA vs UNH · MRNA vs JNJ · MRNA vs LLY | Also: UNH, JNJ, LLY, PFE, MRK, ABBV